---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-311982"
form_type: "8-K"
ticker: "STAA"
cik: "0000718937"
company_name: "STAAR SURGICAL CO"
filed_at: "2025-12-09T23:59:59+00:00"
generated_at: "2026-05-16T13:52:58.006286+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Alcon raises STAAR Surgical acquisition price to $30.75 per share from $28.00

## Summary
- Merger consideration increased to $30.75/share in cash, up from $28.00/share (approx. 9.8% increase).
- Amendment treats RSUs and PSUs as Alcon equity awards; PSUs deemed earned at 100% of target.
- Amendment eliminates 280G gross-up and related tax indemnification arrangements.
- Deal requires stockholder approval and regulatory clearances; proxy statement filed September 16, 2025.

## SEC filing metadata
- accession: 0001193125-25-311982
- form_type: 8-K
- ticker: STAA
- cik: 0000718937
- company_name: STAAR SURGICAL CO
- filed_at: 2025-12-09T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/718937/000119312525311982/0001193125-25-311982-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/718937/000119312525311982/d34553d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-311982
- JSON: https://secwatch.observer/filing/0001193125-25-311982.json
- Plain text: https://secwatch.observer/filing/0001193125-25-311982.txt

## Key facts
- Material Agreements
  STAAR SURGICAL CO amended Amendment No. 2 with Alcon Research, LLC and Rascasse Merger Sub, Inc. valued at $30.75 per share (effective 2025-12-09).
  - Action: amendment
  - Agreement: merger
  - Counterparty: Alcon Research, LLC and Rascasse Merger Sub, Inc.
  - Value: $30.75 per share
  - Effective: 2025-12-09
  source text: On December 9, 2025, STAAR Surgical Company (the “Company”) entered into Amendment No. 2 (the “Amendment”) to the Agreement and Plan of Merger, dated August 4, 2025 (as amended, the “Amended Merger Agreement”), with Alcon Research, LLC (“Alcon”) and Rascasse Merger Sub, Inc. (“Merger Sub”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/718937/000119312525311982/0001193125-25-311982-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.